Cambridge Cognition Holdings Plc engages in the development and marketing of digital solutions to assess brain health. It operates its businesses in pharmaceutical clinical trials, academic research, and healthcare. The company was founded on September 12, 2012 and is headquartered in Bottisham, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company